PET solutions and methods of making PET solutions for medical devices
AssigneeCardiac Pacemakers, Inc.
InventorsJoseph T. Delaney, Jr., David R. Wulfman, Adeniyi O. Aremu, Adegbola O. Adenusi
Life of this patent
Estimating the term…
Abstract
A method of making a solution including poly(ethylene terephthalate). The method includes dissolving poly(ethylene terephthalate) in a solvent mixture to form a solution, the solvent mixture including two solvent components. A Hansen Solubility Parameter Distance between the solvent mixture and HSP coordinates having a dispersion HSP of 18.02 MPa0.5, a polar HSP of 5.56 MPa0.5, and a hydrogen bonding HSP of 14.27 MPa0.5 is less than about 2 MPa0.5.
Claims14
A method of making a solution including poly(ethylene terephthalate), the method comprising:
- dissolving poly(ethylene terephthalate) in a solvent mixture to form a solution, the solvent mixture consisting of two solvent components, a first solvent component and a second solvent component wherein a solubility of the poly(ethylene terephthalate) in the solvent mixture is at least about 2 wt. % at a temperature from about 20° C. to about 25° C., wherein a Hansen Solubility Parameter Distance between the solvent mixture and HSP coordinates having a dispersion HSP of 18.02 MPa0.5, a polar HSP of 5.56 MPa0.5, and a hydrogen bonding HSP of 14.27 MPa0.5 is less than about 2 MPa0.5, wherein:
- the first solvent component is one of (E)-cinnamyl alcohol, 2-allylphenol, 4-propylphenol, chavicol, dihydroeugenol, hawthorn carbinol, hawthorn ethanol, isopropenylphenol, n-butyl salicylate, peony alcohol, or trans anethole and the second solvent component is dl-lactic acid;
- the first solvent component is 2-phenoxy ethanol and the second solvent component is thymol;
- or the first solvent component is n-butyl salicylate and the second solvent component is ethylene glycol;
- the first solvent component is benzyl alcohol and the second solvent component is one of 1-butanol, iso-butanol, and ethylene glycol;
- the first solvent component is thymol and the second solvent component is one of 2,3-butanediol, 2-hydroxy-2-methylpropanoic acid, and 2-methyl-1,3-butanediol;
- or
- the first solvent component is cinnamyl alcohol and the second solvent component is one of 2-methyl-1,3-butanediol, 1-butanol, 2-propanol, or 3-methyl allyl alcohol.
A method for making an implantable medical device including a poly(ethylene terephthalate) layer, the method comprising:
- formulating a poly(ethylene terephthalate) solution by dissolving poly(ethylene terephthalate) in a solvent mixture to form a solution, the solvent mixture consisting of a first solvent component and a second solvent component, wherein a solubility of the poly(ethylene terephthalate) in the solvent mixture is at least about 2 wt. % at a temperature from about 20° C. to about 25° C., wherein a Hansen Solubility Parameter Distance between the solvent mixture and HSP coordinates having a dispersion HSP of 18.02 MPa0.5, a polar HSP of 5.56 MPa0.5, and a hydrogen bonding HSP of 14.27 MPa0.5 is less than about 2 MPa0.5;
- depositing the poly(ethylene terephthalate) solution onto the implantable medical device;
- and
- drying the implantable medical device and evaporating the solvent mixture to leave behind the poly(ethylene terephthalate) layer, wherein the first solvent component of the composition is (E)-cinnamyl alcohol and the second solvent component is dl-lactic acid;
- the first solvent component is 2-phenoxy ethanol and the second solvent component is thymol;
- the first solvent component is 2-allylphenol and the second solvent component is dl-lactic acid;
- the first solvent component cis 4-propylphenol and the second is dl-lactic acid;
- the first solvent component is trans anethole and the second solvent component is dl-lactic acid;
- the first solvent component is benzyl alcohol and the second solvent component is ethylene glycol, iso-butanol, or 1-butanol;
- the first solvent component is chavicol and the second solvent component is dl-lactic acid;
- the first solvent component is cinnamyl alcohol and the second solvent component is 2-methyl-1,3-butanediol, 1-butanol, 2-propanol, or 3-methyl allyl alcohol;
- the first solvent component is dihydroeugenol and the second solvent component is dl-lactic acid;
- the first solvent component is hawthorn carbinol, and the second solvent component is dl-lactic acid;
- the first solvent component is hawthorn ethanol and the second solvent component is dl-lactic acid;
- the first solvent component is isopropenylphenol and the second solvent component is dl-lactic acid;
- the first solvent component is n-butyl salicylate and the second solvent component is dl-lactic acid or ethylene glycol;
- the first solvent component is peony alcohol and the second solvent component is dl-lactic acid;
- or the first solvent component is thymol and the second solvent component is 2,3-butanediol, 2-methyl-1,3-butanediol, or 2-hydroxy-2-methylpropanoic acid.
Dependencies are inferred from the claim text.